Company Filing History:
1 out of 1,746 
1 out of 132 
1 out of 321 
Years Active: 2024
Title: Vasco Meneghini: Innovator in Gene Therapy
Introduction
Vasco Meneghini is a notable inventor based in Bretigny-Sur-Orge, France. He has made significant contributions to the field of gene therapy, particularly in the treatment of sickle cell disorder. His innovative work has led to the development of a patented technology that holds promise for advancing medical treatments.
Latest Patents
Meneghini holds a patent for a "Recombinant lentiviral vector for stem cell-based gene therapy of sickle cell disorder." This invention relates to recombinant lentiviral vectors and their compositions, which are used in conjunction with a catalytically active Cas9 or Cpf1 protein. The methods developed by Meneghini aim to modify the genome of hematopoietic stem/progenitor cells (HSPCs), providing a potential pathway for effective gene therapy.
Career Highlights
Throughout his career, Vasco Meneghini has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Paris Descartes. His experience in these organizations has allowed him to collaborate with leading experts in the field of medical research and innovation.
Collaborations
Meneghini has collaborated with Annarita Miccio, contributing to advancements in gene therapy and stem cell research. Their joint efforts have focused on developing innovative solutions for genetic disorders.
Conclusion
Vasco Meneghini's work in gene therapy exemplifies the impact of innovation in medicine. His patented technology offers hope for patients suffering from sickle cell disorder and highlights the importance of continued research in this vital field.